Contributions from private donors, institutional sponsors, or corporate sponsors will gladly be accepted to help support the Fetal Heart Society’s Mission and Aims. Your support will allow us to achieve our goal of improved care for fetuses with cardiovascular disease through multicenter collaboration across subspecialties and disciplines If you are considering a donation and have questions, please…
Mary T. Donofrio, MD, and Jack Rychik, MD, on Behalf of the Fetal Heart Society Governing Board and
Steering Committee*, Washington, District of Columbia; and Philadelphia, Pennsylvania
Congenital heart abnormalities are the most common birth defect among all geographic regions and racial and ethnic backgrounds.1 With advancements in imaging technology, fetal echocardiography provides the opportunity to diagnose complex cardiovascular conditions from the first trimester of pregnancy onward. As a consequence, the prenatal diagnosis and management of fetuses with cardiac anomalies is emerging as an important component of health care worldwide. Examination of the fetal heart and care of fetuses with abnormalities in the cardiovascular system have evolved considerably over the past two decades.